Thompson Davis & Co’s Rosetta Genomics Ltd. ROSG Stock Holding History

Thompson Davis & Co’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-83	Closed	–	–	1321
2014 Q2	$0	Buy	+83	New	+$4.11K	﹤0.01%	925

Other funds holding ROSG

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Thompson Davis & Co's ROSG Position: Q3 2014 in Review

Thompson Davis & Co sold out of Rosetta Genomics Ltd. (ROSG) in Q3 2014, closing a stake of 83 shares.

Thompson Davis & Co first reported a position in ROSG in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 14 funds tracked by Wall St. Rank hold ROSG as of Q3 2014.

Thompson Davis & Co reported no remaining Rosetta Genomics Ltd. position as of Q3 2014 after selling out during the quarter.
Thompson Davis & Co sold 83 Rosetta Genomics Ltd. shares in Q3 2014.
Thompson Davis & Co first reported a position in Rosetta Genomics Ltd. in Q2 2014 and held it in 1 quarter.
Thompson Davis & Co's Rosetta Genomics Ltd. position peaked at $0 in Q2 2014.
14 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q3 2014.

Based on Thompson Davis & Co's 13F filing for Q3 2014, filed 4 Nov 2014.